The study uses a mouse gestational fluoxetine exposure study with a higher than typical dose of drug (16 mg/kg/d) administered in drinking water sweetened with saccharin to dams (an unusual approach in an attempt to reduce stress) and also seeks to ameliorate deficits in offspring with fluoxetine treatment and a Celf6 mutant line of mice exhibiting mild autism-like behavioral phenotype along with wild type mice. The gene discussed is CELF6; the disease is autism.